Thanks to webmeeting technology the Rein in Sarcoma Board was able to carry out business in spite of a very snowy day! We were disappointed to forego the potluck dinner and being able to meet in person, but glad we had a Plan B.
Tom McCarthy reported that the organization grew by almost 30% in 2016 furthering our mission and allowing us to make significant strategic decisions for 2017. The Board approved $148,000 in new Sarcoma research grants at the University of Minnesota that will soon be made public. Funding of a second year of research grants at Mayo Clinic, Children's Hospitals and Clinics and SARC was approved, as was funding for RIS Sarcoma Scholars at both at the University of Minnesota and Mayo Medical Schools for the 2018-2019 academic year.
The Board thanked Theresa Baultrippe, Courtney Clemens, Dr. Christian Ogilvie as retiring board members. Special thanks and recognition were given to Sue and Pete Wyckoff who are retiring as Board Member and Board Member/President. After 17 years of nurturing and growing Rein in Sarcoma, which was founded by their daughter Karen, Pete and Sue are stepping back from leadership of the organization. We are happy to report that they will stay involved, primarily in the area of RIS education programming and fostering collaboration with other sarcoma related organizations.
Our Nominating Committee presented five excellent candidates who were elected to serve for three-year terms. Read more about the new board members. New officers are
President: Debra Cossette
Vice-President: Blake Hastings
Secretary: Chelsey Olafson
Treasurer: Tom McCarthy
The Development Committee made a recommendation to move ahead with the hiring of a RIS Development Director, which was approved by the Board. The hiring of a part-time Health Education Program Manager was proposed by the Red Flags Education Committee and approved by the Board. The Talent and Resource Committee, along with members from the Development and Red Flags Committees are finalizing the position descriptions and the hiring timelines. Further details will be posted on our website and on several job sites in the coming weeks.
The Strategic Planning Committee has been formed and will be working towards a final plan to present at the next Board meeting on April 30th. This will help set the direction for Rein in Sarcoma for the next several years. The committee will be looking at several different avenues to get input from the RIS community; we hope you will take the time to let us know your thoughts about Rein in Sarcoma's mission, programs and priorities going forward.